'I should have taken that further' - missed opportunities during cardiovascular risk assessment in patients with psoriasis in UK primary care settings: a mixed-methods study

Health Expectations : an International Journal of Public Participation in Health Care and Health Policy
P A NelsonIMPACT Team (Identification and Management of Psoriasis-Associated Co-morbidiTy)

Abstract

Unhealthy lifestyle is common in psoriasis, contributing to worsening disease and increased cardiovascular disease (CVD) risk. CVD risk communication should improve patients' understanding of risk and risk-reducing behaviours; however, the effectiveness of risk screening is debated and evaluation currently limited. To examine the process of assessing for and communicating about CVD risk in the context of psoriasis. Mixed-methods study in English general practices to (i) determine proportions of CVD risk factors among patients with psoriasis at risk assessment and (ii) examine patient and practitioner experiences of risk communication to identify salient 'process' issues. Audio recordings of consultations informed in-depth interviews with patients and practitioners using tape-assisted recall, analysed with framework analysis. Patients with psoriasis (n = 287) undergoing CVD risk assessment; 29 patients and 12 practitioners interviewed. A high proportion of patients had risk factor levels apparent at risk assessment above NICE recommendations: very high waist circumference (52%), obesity (35%), raised blood pressure (29%), smoking (18%) and excess alcohol consumption (18%). There was little evidence of personalized discussion abo...Continue Reading

References

Mar 24, 1990·BMJ : British Medical Journal·K PoikolainenP Kärkkäinen
Jan 1, 1984·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·N D Weinstein
Jul 17, 1993·BMJ : British Medical Journal·S RollnickN Stott
Jun 23, 2000·Journal of the American Academy of Dermatology·K E Smith, N A Fenske
Sep 5, 2001·Quality in Health Care : QHC·A Edwards, G Elwyn
Aug 15, 2002·Journal of Advanced Nursing·Maria Jose Duaso, Philip Cheung
Apr 11, 2003·Lancet·Mark Lebwohl
May 6, 2003·Health Education Research·C M McBrideI M Lipkus
Sep 27, 2003·BMJ : British Medical Journal·Andy Alaszewski, Tom Horlick-Jones
Dec 18, 2003·JAMA : the Journal of the American Medical Association·Janet M TorpyRichard M Glass
Feb 10, 2004·Preventive Medicine·Susan A Flocke, Kurt C Stange
Apr 16, 2004·The Journal of Investigative Dermatology. Symposium Proceedings·John de KorteJan D Bos
Dec 21, 2004·The British Journal of Dermatology·H L RichardsC E M Griffiths
May 28, 2005·The Diabetes Educator·Paul A EstabrooksRussell E Glasgow
Dec 21, 2005·Archives of Dermatology·Cristina FortesDamiano Abeni
Oct 6, 2006·Archives of Dermatological Research·Dorothea M SommerMichael Weichenthal
Oct 13, 2006·JAMA : the Journal of the American Medical Association·Joel M GelfandAndrea B Troxel
Nov 3, 2007·The American Journal of Medicine·Arathi R SettyHyon K Choi
Apr 1, 2008·The American Journal of Medicine·Giampiero Favato
Aug 30, 2008·The American Journal of Medicine·Hong K Kim, Alex Manini
Sep 8, 2009·Acta Dermato-venereologica·Katarina WolkMona Ståhle
Dec 10, 2009·Dermatology : International Journal for Clinical and Investigative Dermatology·S GerdesU Mrowietz
May 18, 2010·Patient Education and Counseling·Cherry-Ann WaldronGlyn Elwyn
Oct 14, 2010·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·John CapePeter Salmon
Dec 25, 2010·Patient Education and Counseling·Deborah J CohenSusan A Flocke
Feb 8, 2011·Lancet·Mariel M FinucaneUNKNOWN Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index)
Apr 25, 2012·BMC Family Practice·Steven McPhail, Mandy Schippers
Jun 20, 2012·BMJ : British Medical Journal·Haroon AhmedAdrian G K Edwards
Jul 24, 2012·Patient Education and Counseling·Kimberly A GudzuneWendy L Bennett
Aug 14, 2012·The British Journal of Dermatology·P A NelsonUNKNOWN IMPACT Team
Sep 28, 2012·The Journal of Investigative Dermatology·Rosa ParisiUNKNOWN Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team
Nov 22, 2012·BMJ : British Medical Journal·Domhnall MacAuley
Dec 12, 2012·Molecular Nutrition & Food Research·Peter Schreier
Feb 5, 2013·Family Practice·Macide ArtacChristopher Millett
Feb 13, 2013·The Australasian Journal of Dermatology·Chris S BakerAnna Braue
Mar 27, 2013·The Journal of Investigative Dermatology·Eleanor J SamarasekeraCatherine H Smith
Jun 20, 2013·JAMA : the Journal of the American Medical Association·Lasse T KrogsbøllPeter C Gøtzsche

❮ Previous
Next ❯

Citations

Oct 23, 2015·International Journal of Behavioral Medicine·Chris KeyworthLis Cordingley
Apr 2, 2015·The British Journal of Dermatology·P A Nelson
Mar 19, 2016·The British Journal of Dermatology·M K RutterC E M Griffiths
Apr 14, 2017·The British Journal of Dermatology·P A NelsonUNKNOWN Identification and Management of Psoriasis-Associated Co morbidiTy (IMPACT) team
Jul 5, 2016·The British Journal of Dermatology·A ChisholmUNKNOWN Identification and Management of Psoriasis-Associated ComorbidiTy (IMPACT) Team
Aug 30, 2018·The British Journal of Dermatology·R B WarrenUNKNOWN PSORT Consortium and on behalf of the BADBIR Study Group
Nov 26, 2018·Journal of Cellular and Molecular Medicine·Yanrong LiuCheng Yang
Jan 1, 2019·The British Journal of Dermatology·M H LarsenA K Wahl
Oct 17, 2018·American Journal of Clinical Dermatology·Marie Hamilton LarsenAstrid Klopstad Wahl
Jun 24, 2020·International Journal of Environmental Research and Public Health·Francis A AlbertBunmi S Malau-Aduli
Jun 3, 2021·NPJ Primary Care Respiratory Medicine·Emilie ManoliosLjiljana Jovic
Jun 16, 2021·The British Journal of Dermatology·I Y K IskandarUNKNOWN on behalf the British Association of Dermatologists Biologics and Immunomodulators Register and Psoriasis Stratification to

❮ Previous
Next ❯

Software Mentioned

NVivo
R

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.